Structural basis for dimerization quality control

Elijah L. Mena(Howard Hughes Medical Institute), Michael Rapé(QB3), John Kuriyan(Vanderbilt University), Christine L. Gee(QB3), Brandon G. Lew(Howard Hughes Medical Institute), David Akopian(University of California, Berkeley), Predrag Jevtić(Howard Hughes Medical Institute), Basil J. Greber(QB3), Eva Nogales(QB3)
Nature
August 19, 2020
10.1038/s41586-020-2636-7
Cited by 61

Related Papers

Crystallographic <i>R</i> Factor Refinement by Molecular Dynamics
|Science|1987|2k
Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
|Science|2000|1.8k
The Conformational Plasticity of Protein Kinases
|Cell|2002|1.8k
An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor Receptor
|Cell|2006|1.6k
Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia
|Cancer Cell|2002|1.6k